Atlas Trials

Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis

Clinical trial NCT01490411 · COMPLETED

Trial details

NCT number
NCT01490411
Sponsor
Allergopharma GmbH & Co. KG
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Allergic Rhinoconjunctivitis
Start date
2010-10-01
Primary completion
2011-04-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.